Found 4 matching trials
A "negative"dendritic Cell-based Vaccine for the Treatment of Multiple Sclerosis: a First-in-human Clinical Trial
PHASE1A first-in-human clinical trial to treat patients with multiple sclerosis b...
Location
Antwerp University Hospital
A Phase IIa Study of Vitamin D3 Tolerogenic Dendritic Cells (tolDC) for Multiple Sclerosis
PHASE2The investigators propose to design and conduct a phase IIa clinical trial ...
Location
Universitair Ziekenhuis Antwerpen (UZA)
An Immunotherapy Vaccine (PIpepTolDC) for the Treatment of Patients With Type 1 Diabetes
PHASE1This phase I trial investigates the side effects of PIpepTolDC vaccine in t...
Status
Active Not Recruiting
Location
City of Hope Medical Center
A Clinical Trial Evaluating the Safety and Efficacy of Myelin-peptide Loaded tolDC as Treatment for MS
PHASE2The investigators propose to design and conduct a phase II clinical trial t...
Location
Antwerp University Hospital